Literature DB >> 23107854

Purposeful interaction: ways Latino men communicate about prostate cancer.

Sally L Maliski1, Sarah E Connor, Mark S Litwin.   

Abstract

PURPOSE/
OBJECTIVES: To develop a descriptive framework of the communication processes used by Latinos with prostate cancer to communicate about their diagnosis. RESEARCH APPROACH: A constructivist grounded theory approach was used to analyze and build a descriptive framework from semistructured interviews.
SETTING: A university-affiliated urban hospital in southern California. PARTICIPANTS: 30 Latinos treated for prostate cancer, who had at least one first-degree male relative (FDMR), and who lived near the medical center. METHODOLOGIC APPROACH: Semistructured interviews with bilingual Latinos were conducted in participants' homes in the language they preferred. Individual and collaborative analyses of translated transcripts were guided by constructivist grounded theory.
FINDINGS: Analysis uncovered an overarching process of purposeful interacting. Components of the process included occasionally overlapping spheres of communication, which were connected to purposes and content. Balanced in and influenced by the spheres were cross-cutting processes of respectful silence and selective disclosure.
CONCLUSIONS: Men communicated different content about their prostate cancer to people representing different reference groups. Respectful silence and selective disclosure could be viewed as men's enactment of social interaction-using and choosing words based on the symbolic meaning the men perceived would have their intended meaning for the people in each of the spheres.
INTERPRETATION: Culturally sensitive educational interventions should be targeted at Latinos with prostate cancer to understand risk and encourage disclosure to FDMRs.

Entities:  

Mesh:

Year:  2012        PMID: 23107854      PMCID: PMC3686632          DOI: 10.1188/12.ONF.603-608

Source DB:  PubMed          Journal:  Oncol Nurs Forum        ISSN: 0190-535X            Impact factor:   2.172


  8 in total

1.  To tell or not to tell: patterns of disclosure among men with prostate cancer.

Authors:  R E Gray; M Fitch; C Phillips; M Labrecque; K Fergus
Journal:  Psychooncology       Date:  2000 Jul-Aug       Impact factor: 3.894

2.  Renegotiating masculine identity after prostate cancer treatment.

Authors:  Sally L Maliski; Steve Rivera; Sarah Connor; Griselda Lopez; Mark S Litwin
Journal:  Qual Health Res       Date:  2008-10-27

3.  Cancer statistics, 2012.

Authors:  Rebecca Siegel; Deepa Naishadham; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2012-01-04       Impact factor: 508.702

4.  Disclosure of diagnosis and treatment among early stage prostate cancer survivors.

Authors:  Trent Jackson; Kimberly Davis; Lisa Haisfield; David Dawson; John Lynch; James Regan; Arnold Kwart; Barlow Lynch; Kathryn Taylor
Journal:  Patient Educ Couns       Date:  2009-09-22

5.  Cancer and communication: similarities and differences of men with cancer from six different ethnic groups.

Authors:  I Papadopoulos; S Lees
Journal:  Eur J Cancer Care (Engl)       Date:  2004-05       Impact factor: 2.520

Review 6.  Health disparities in the Latino population.

Authors:  William A Vega; Michael A Rodriguez; Elisabeth Gruskin
Journal:  Epidemiol Rev       Date:  2009-08-27       Impact factor: 6.222

7.  Disclosing a cancer diagnosis to friends and family: a gendered analysis of young men's and women's experiences.

Authors:  Shona Hilton; Carol Emslie; Kate Hunt; Alison Chapple; Sue Ziebland
Journal:  Qual Health Res       Date:  2009-04-02

Review 8.  A review of prostate-specific antigen screening prevalence and risk perceptions for first-degree relatives of men with prostate cancer.

Authors:  M E McDowell; S Occhipinti; R A Gardiner; P D Baade; S K Steginga
Journal:  Eur J Cancer Care (Engl)       Date:  2009-11       Impact factor: 2.520

  8 in total
  1 in total

1.  Latino men and familial risk communication about prostate cancer.

Authors:  Elisabeth M Hicks; Mark S Litwin; Sally L Maliski
Journal:  Oncol Nurs Forum       Date:  2014-09       Impact factor: 2.172

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.